{"nct_id":"NCT04494425","title":"Study of Trastuzumab Deruxtecan (T-DXd) vs Investigator's Choice Chemotherapy in HER2-low, Hormone Receptor Positive, Metastatic Breast Cancer","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-06","start_date":"2020-07-24","start_date_type":"ACTUAL","primary_completion_date":"2024-03-18","primary_completion_date_type":"ACTUAL","completion_date":"2026-06-19","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["AZN"]}